PHK
CALA

Point72 Hong Kong’s Calithera Biosciences, Inc CALA Stock Holding History

Point72 Hong Kong’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37
Closed -$2K – 2493
2021
Q1 		$2K Buy
+37
New +$2.15K ﹤0.01% 1716
2020
Q4 		– Sell
-44
Closed -$3K – 2148
2020
Q3 		$3K Sell
44
-10
-19% -$873 ﹤0.01% 1110
2020
Q2 		$6K Sell
54
-56
-51% -$6.65K ﹤0.01% 1031
2020
Q1 		$10K Sell
110
-113
-51% -$13.5K ﹤0.01% 695
2019
Q4 		$26K Buy
+223
New +$16.8K 0.01% 836
2019
Q3 		– Sell
-77
Closed -$6K – 1469
2019
Q2 		$6K Buy
+77
New +$8.74K ﹤0.01% 916
2018
Q2 		– Sell
-122
Closed -$15K – 1284
2018
Q1 		$15K Buy
+122
New +$19K 0.01% 661

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's CALA Position: Q2 2021 in Review

Point72 Hong Kong sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 37 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in CALA in Q1 2018 and held it in 7 quarters. The position peaked at $26K in Q4 2019. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Point72 Hong Kong reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 37 Calithera Biosciences, Inc shares in Q2 2021, an estimated $2K.
  • Point72 Hong Kong first reported a position in Calithera Biosciences, Inc in Q1 2018 and held it in 7 quarters.
  • Point72 Hong Kong's Calithera Biosciences, Inc position peaked at $26K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.